Abstract:The prevalence of diabetes steadily increases worldwide mirroring the prevalence of obesity. Endoplasmic reticulum (ER) stress is activated in diabetes and contributes to β-cell dysfunction and apoptosis through the activation of a terminal unfolded protein response (UPR). Our results uncover a new role for Bax Inhibitor-One (BI-1), a negative regulator of inositol-requiring enzyme 1 (IRE1α) in preserving β-cell health against terminal UPR-induced apoptosis and pyroptosis in the context of supraphysiological loads of insulin production. BI-1- deficient mice experience a decline in endocrine pancreatic function in physiological and pathophysiological conditions, namely obesity induced by high-fat diet (HFD). We observed early-onset diabetes characterized by hyperglycemia, reduced serum insulin levels, β-cell loss, increased pancreatic lipases and pro-inflammatory cytokines, and the progression of metabolic dysfunction. Pancreatic section analysis revealed that BI-1 deletion overburdens unfolded proinsulin in the ER of β-cells, confirmed by ultrastructural signs of ER stress with overwhelmed IRE1α endoribonuclease (RNase) activity in freshly isolated islets. ER stress led to β-cell dysfunction and islet loss, due to an increase in immature proinsulin granules and defects in insulin crystallization with the presence of Rod-like granules. These results correlated with the induction of autophagy, ER phagy, and crinophagy quality control mechanisms, likely to alleviate the atypical accumulation of misfolded proinsulin in the ER. In fine, BI-1 in β-cells limited IRE1α RNase activity from triggering programmed β-cell death through apoptosis and pyroptosis (caspase-1, IL-1β) via NLRP3 inflammasome activation and metabolic dysfunction. Pharmaceutical IRE1α inhibition with STF-083010 reversed β-cell failure and normalized the metabolic phenotype. These results uncover a new protective role for BI-1 in pancreatic β-cell physiology as a stress integrator to modulate the UPR triggered by accumulating unfolded proinsulin in the ER, as well as autophagy and programmed cell death, with consequences on β-cell function and insulin secretion.

NF90-NF45 is essential for β cell compensation under obesity-inducing metabolic stress through suppression of p53 signaling pathway

Nuclear factor-Y mediates pancreatic β-cell compensation by repressing reactive oxygen species-induced apoptosis under metabolic stress

Nuclear factor-Y mediates pancreatic -cell compensation by repressing reactive oxygen species-induced apoptosis under metabolic stress

Nuclear Factor-Y in Mouse Pancreatic Β-Cells Plays a Crucial Role in Glucose Homeostasis by Regulating Β-Cell Mass and Insulin Secretion

Silencing of Functional P53 Attenuates NAFLD by Promoting HMGB1-related Autophagy Induction

Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneity

FoxO1 Plays an Important Role in Regulating Β-Cell Compensation for Insulin Resistance in Male Mice.

Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity.

Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death

NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-induced Dysfunction and Apoptosis of Β-Cells Via JNK, P38 MAPK and P53 Pathways.

Nuclear Factor Κb–inducing Kinase Activation As a Mechanism of Pancreatic Β Cell Failure in Obesity

Role of transcription factor NFAT in glucose and insulin homeostasis

Obesity-induced upregulation of miR-483-5p impairs the function and identity of pancreatic β-cells

Peroxisome proliferator-activated receptor β / δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation

364-OR: Beta-Cell SF1 As a Thermogenic Regulator Against Diet-Induced Obesity in Mice—Elucidating Its Role in Islet—Adipose Cross Talk

CBP/p300 HAT maintains the gene network critical for β cell identity and functional maturity

Inactivation of NF-κB p50 Leads to Insulin Sensitization in Liver through Post-translational Inhibition of p70S6K

Peroxisome Proliferator-Activated Receptorβ/δ Activation is Essential for Modulating P-Foxo1/foxo1 Status in Functional Insulin-Positive Cell Differentiation.

Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function

Cnc-Bzip Protein Nrf1-Dependent Regulation of Glucose-Stimulated Insulin Secretion

Cellular Production of N-3 Pufas and Reduction of N-6-To-N-3 Ratios in the Pancreatic Beta-Cells and Islets Enhance Insulin Secretion and Confer Protection Against Cytokine-Induced Cell Death